Francesco Pegoraro

675 citations
29 papers · 257 indexed · h-index 9
Topics
Histiocytic Disorders and Treatments (14 papers)Eosinophilic Disorders and Syndromes (5 papers)Parvovirus B19 Infection Studies (4 papers)
Partner nations
ItalyFranceIsrael

In The Last Decade

Francesco Pegoraro

26 papers receiving 252 citations

Peers

Francesco Pegoraro
Comparison fields: 5 of 52
  • Physiology 97
  • Infectious Diseases 77
  • Surgery 64
  • Rheumatology 55
  • Immunology 40
Replace K. Toledano with:
K. Toledano Israel
Argyro Bizaki Finland
Elrazi Ali Qatar
H. Harmouche Morocco
Leonardo Caroti Italy
Raphaël Cauchois France
Raphaël Lhote France
Dorota Bartoszek Poland
Karina Rossi Bonfiglioli Brazil
Inderpal Randhawa United States
Francesco Pegoraro relative to K. Toledano Israel K. Toledano's profile →
Citations per field
00.5×8.4×
K. Toledano · 1×
Citations per year

Countries citing papers authored by Francesco Pegoraro

Since Specialization
Citations

This map shows the geographic impact of Francesco Pegoraro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Pegoraro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Pegoraro more than expected).

Fields of papers citing papers by Francesco Pegoraro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Pegoraro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Pegoraro. The network helps show where Francesco Pegoraro may publish in the future.

Co-authorship network of co-authors of Francesco Pegoraro

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Pegoraro. A scholar is included among the top collaborators of Francesco Pegoraro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Pegoraro. Francesco Pegoraro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 1
4 1
5 2
6 1
7 1
8 8
9 28
10 24
11 1
12 12
13 2
14 3
15 2
16 10
17 5
18 55
19 19
20 42

About Francesco Pegoraro

Francesco Pegoraro is a scholar working on Physiology, Genetics and Infectious Diseases, having authored 29 papers that have together received 257 indexed citations. Recurring topics across this work include Histiocytic Disorders and Treatments (14 papers), Eosinophilic Disorders and Syndromes (5 papers) and Parvovirus B19 Infection Studies (4 papers). The work is most often cited by research in Infectious Diseases (77 citations), Physiology (97 citations) and Rheumatology (55 citations). Francesco Pegoraro has collaborated with scholars based in Italy, France and Israel. Frequent co-authors include Augusto Vaglio, Frédéric Charlotte, Julien Haroche, Giuseppe Indolfi, Claudio Favre, Sandra Trapani, Matthias Papo, Giuseppe Favacchio, Andrea Lania and Gherardo Mazziotti. Their work appears in journals such as Blood, PLoS ONE and Kidney International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026